Positive data for Veru Inc.’s enobosarm lend more weight to the potential progress of the company’s body-mass preservation program in patients taking Wegovy (semaglutide). The side effect of lean mass ...
With obesity rates tripling over the past 60 years, GLP-1 medications dominated the conversation in 2024 as an effective solution for this pervasive issue. But are they a one-shot deal?
Here’s a glimpse of our insights – discover how you can access the full dataset here. 1. Nearly two-thirds say their shopping habits have changed since they began taking a GLP-1 medication for weight ...
Market News Alerts Updates that DarioHealth Corp. (Nasdaq: DRIO) is taking another bold step into the rapidly growing weight-loss market, now projected to exceed $100 billion annually by 2030. The ...